Barbara Tilley to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Barbara Tilley has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.265
-
Screening potential therapies: lessons learned from new paradigms used in Parkinson disease. Stroke. 2007 Feb; 38(2 Suppl):800-3.
Score: 0.066
-
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
Score: 0.062
-
Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
Score: 0.060
-
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 2022 Oct 06; 23(1):855.
Score: 0.049
-
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958):1929-35.
Score: 0.028